VLI-03B

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVLI-03B
Drug Alias NameIBDV-903/78-INF alphalive attenuated recombinant infectious bursal disease virus vaccine (DNAtrix)live attenuated recombinant infectious bursal disease virus vaccine (VectorLogics)live recombinant IBDV vaccines (DNAtrix)live recombinant IBDV vaccines (VectorLogics) +[6] 
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Development/production technology > Recombinant vector vaccine +[4] 
Mechanisms of ActionInterferon alpha ligand
TargetsInterferon alpha
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVectorlogics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVectorlogicsDnatrix Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A
Related LinksN/A